AMRN
Closed
Amarin Corporation Plc
16.891
+0.671 (+4.14%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 16.22
Day's Range: 15.78 - 16.975
Send
sign up or login to leave a comment!
When Written:
1.5
Amarin Corporation PLC is a biopharmaceutical company that focuses on developing and commercializing therapeutics to improve cardiovascular health. The company's lead product, Vascepa, is a prescription omega-3 fatty acid medication that is used to treat patients with high triglyceride levels. Amarin is also developing other products that target cardiovascular disease, including drugs that target LDL cholesterol and inflammation. The company was founded in 1989 and is headquartered in Dublin, Ireland, with operations in the United States. Amarin is publicly traded on the NASDAQ stock exchange under the ticker symbol AMRN.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








